Literature DB >> 18806904

Clobetasol propionate--where, when, why?

Ragna Pels1, Wolfram Sterry, Jürgen Lademann.   

Abstract

Clobetasol propionate is the most potent of all topical steroids. It is successfully applied in the treatment of various skin diseases such as atopic dermatitis, psoriasis and vulvar lichen sclerosus. The therapy is, however, mainly symptomatic. A preventive effect is only reported in the treatment of the latter. Clobetasol propionate exerts antiinflammatory, immunosuppressive and antimitotic effects influencing the growth, differentiation and function of various cells and inhibiting cytokine production. Seven different dosage forms are available to deliver the drug to the living cells of the skin. Their choice might additionally affect patient compliance. The potency of clobetasol propionate, however, is accompanied by local and systemic side effects, such as skin atrophy and hypothalamic-pituitary-adrenal axis suppression. Patients applying clobetasol propionate must be well instructed in how to use it. Physicians prescribing clobetasol propionate should consider a diversity of factors and be able to answer the questions where, when and why. Copyright 2008 Prous Science, S.A.U. or its licensors. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18806904     DOI: 10.1358/dot.2008.44.7.1122221

Source DB:  PubMed          Journal:  Drugs Today (Barc)        ISSN: 1699-3993            Impact factor:   2.245


  3 in total

Review 1.  Exogenous Cushing's syndrome due to topical corticosteroid application: case report and review literature.

Authors:  Therdpong Tempark; Voraluk Phatarakijnirund; Susheera Chatproedprai; Suttipong Watcharasindhu; Vichit Supornsilchai; Siriwan Wananukul
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

Review 2.  Topical corticosteroid-induced skin atrophy: a comprehensive review.

Authors:  Laurent Barnes; Gurkan Kaya; Victoria Rollason
Journal:  Drug Saf       Date:  2015-05       Impact factor: 5.606

Review 3.  Novel Dermal Delivery Cargos of Clobetasol Propionate: An Update.

Authors:  Anroop B Nair; Sunil Kumar; Pooja Dalal; Chahat Nagpal; Sweta Dalal; Rekha Rao; Nagaraja Sreeharsha; Shery Jacob
Journal:  Pharmaceutics       Date:  2022-02-09       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.